Pregnant
0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programPregnant Women s Views About the Ethics of Prenatal Whole Genome SequencingN/A1 trial
Active Trials
Genome & CompanyKorea - Suwon
1 programPregnant Women s Views About the Ethics of Prenatal Whole Genome SequencingN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Dynavax TechnologiesHEPLISAV-B
Human BioSciencesPregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Clinical Trials (2)
Total enrollment: 853 patients across 2 trials
DV2-HBV-27: Observational Pregnancy Registry
Start: Feb 2021Est. completion: Dec 2024300 patients
N/AUnknown
NCT03105492Human BioSciencesPregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Start: Jun 2017Est. completion: Apr 2019553 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.